HSBC Research Lowers KINGDEE INT'L (00268.HK) Price Target to $17.7, Maintains Buy Rating
Share Price Movement: KINGDEE INT'L's share price has decreased by 3.027% recently, despite a 24% year-to-date increase, amid concerns about AI's impact on software.
HSBC Global Research Insights: HSBC believes that while AI can enhance ERP systems, it will not replace them due to the complexity and high expectations of corporate clients.
Revenue Model Differences: Unlike the US software sector, KINGDEE INT'L charges based on the number of modules used rather than a seat-based model, reflecting the competitive landscape in China.
Profit Forecast Adjustments: HSBC has lowered its net profit forecasts for KINGDEE INT'L by 14-25% for 2025-2027, while maintaining a Buy rating and adjusting the target price from $18.2 to $17.7.
Trade with 70% Backtested Accuracy
Analyst Views on 00268
About the author
HSI Rises 435 Points as JD-SW Jumps 10% and JD LOGISTICS Soars 23%
Hong Kong Stock Market Performance: Hong Kong stocks saw significant gains, with the HSI rising 1.7% to 25,757, the HSCEI up 2.1% to 8,628, and the HSTECH increasing 3.2% to 4,947, alongside a total market turnover of $292.766 billion.
JD Series Surge: JD-SW shares surged nearly 10% to $106.6 following positive results, while JD LOGISTICS experienced a remarkable 23% increase, making it the largest gainer among blue chips.
Tech Stocks Rally: Major tech companies like TENCENT, BABA-W, and MEITUAN-W saw their stock prices rise between 3.1% and 5.2%, reflecting a broader positive trend in the tech sector.
BILIBILI-W Decline: Despite reporting a 94% increase in adjusted net profit, BILIBILI-W's stock price fell by 4.5%, contrasting with other companies that experienced gains.
HSI Rises 468 Points at Midday; JD Jumps Over 8% After Earnings; Tencent, Alibaba, and Meituan Gain 4%
Market Performance: The Hong Kong bourse experienced a strong morning session, with the Hang Seng Index (HSI) rising 468 points (1.85%) to close at 25,789, driven by gains in technology stocks.
JD Companies Surge: JD's various subsidiaries saw significant stock price increases following their earnings release, with JD Logistics soaring 21.3% and JD Health rising 3.5%.
Tech Stocks Gains: Major tech companies like Tencent, Alibaba, and Meituan also posted notable gains, with increases ranging from 3.9% to 4.3%, contributing to the overall market upswing.
AI and Cloud Stocks: AI-related stocks and cloud service providers experienced growth, with companies like Kingsoft Cloud and various AI firms seeing increases of 3.7% to 5.7%, while Bilibili's stock fell despite reporting a significant profit increase.
HSBC Research Lowers KINGDEE INT'L (00268.HK) Price Target to $17.7, Maintains Buy Rating
Share Price Movement: KINGDEE INT'L's share price has decreased by 3.027% recently, despite a 24% year-to-date increase, amid concerns about AI's impact on software.
HSBC Global Research Insights: HSBC believes that while AI can enhance ERP systems, it will not replace them due to the complexity and high expectations of corporate clients.
Revenue Model Differences: Unlike the US software sector, KINGDEE INT'L charges based on the number of modules used rather than a seat-based model, reflecting the competitive landscape in China.
Profit Forecast Adjustments: HSBC has lowered its net profit forecasts for KINGDEE INT'L by 14-25% for 2025-2027, while maintaining a Buy rating and adjusting the target price from $18.2 to $17.7.
HSI Closes Down 491 Points; Tech, Pharma, and Chinese Insurers Decline, While STANCHART Surges Over 3% After Earnings Report
Market Performance: The HSI fell by 491 points (1.8%) to 26,590, with the HSCEI and HSTECH also experiencing declines of 2.1%, closing at 9,007 and 5,270 respectively, amid a total market turnover of HKD250.992 billion.
Tech Stock Declines: Major tech stocks like TENCENT, BABA-W, and MEITUAN-W saw significant drops, with short selling ratios indicating high market activity, reflecting a broader downturn in the tech sector.
Pharmaceutical Sector Struggles: Pharmaceutical stocks continued to decline, with CSPC PHARMA and SINO BIOPHARM among the biggest losers, as short selling activity remained high in this sector.
Financial Sector Highlights: STANCHART reported a 3.1% increase in stock price after announcing a significant rise in dividend distribution, contrasting with the overall negative trend seen in Chinese insurers, which experienced declines.
HSI Declines 523 Points at Midday; KNOWLEDGE ATLAS Gains 20%; Tech, Pharma, and Chinese Insurers Underperform
Market Performance: The HSI fell 523 points (1.9%) to 26,558, with the HSCEI down 190 points (2.1%) and the HSTECH dropping 127 points (2.4%), amid a total turnover of HKD138.679 billion.
Tech Stocks Decline: Major tech stocks like TENCENT, BABA-W, and MEITUAN-W experienced significant declines, with short selling ratios indicating increased bearish sentiment.
AI and Robotics Sector Struggles: Stocks in the AI sector, including SENSETIME-W and PHANCY, saw substantial losses, while robotics stocks like DOBOT plunged over 10%.
Pharmaceutical and Insurance Stocks Down: Pharma stocks such as CSPC PHARMA and Chinese insurers like CHINA LIFE faced declines of 4-6%, reflecting a broader downturn in these sectors.
G Sachs: KINGDEE INT'L (00268.HK) Anticipated to Report Over RMB60M Profit Last Year, Falling Short of Projections; Target Price Reduced to $18.21
Goldman Sachs Outlook: Goldman Sachs maintains a positive outlook on KINGDEE INT'L (00268.HK), leveraging AI and corporate data to enhance productivity, despite a recent stock decline of 5.645%.
Profit Forecast: KINGDEE INT'L is expected to turn a profit in 2025, projecting a net profit of RMB60-100 million, although this is lower than previous estimates of RMB178 million.
Revised Profit Estimates: Goldman Sachs has reduced its profit forecasts for KINGDEE INT'L for 2025-2027 by 47%, 8%, and 6% respectively, citing higher-than-expected operating expenses.
Target Price Adjustment: The broker has lowered its target price for KINGDEE INT'L from $18.98 to $18.21 while maintaining a "Buy" rating.
HSI Rises 435 Points as JD-SW Jumps 10% and JD LOGISTICS Soars 23%
Hong Kong Stock Market Performance: Hong Kong stocks saw significant gains, with the HSI rising 1.7% to 25,757, the HSCEI up 2.1% to 8,628, and the HSTECH increasing 3.2% to 4,947, alongside a total market turnover of $292.766 billion.
JD Series Surge: JD-SW shares surged nearly 10% to $106.6 following positive results, while JD LOGISTICS experienced a remarkable 23% increase, making it the largest gainer among blue chips.
Tech Stocks Rally: Major tech companies like TENCENT, BABA-W, and MEITUAN-W saw their stock prices rise between 3.1% and 5.2%, reflecting a broader positive trend in the tech sector.
BILIBILI-W Decline: Despite reporting a 94% increase in adjusted net profit, BILIBILI-W's stock price fell by 4.5%, contrasting with other companies that experienced gains.
HSI Rises 468 Points at Midday; JD Jumps Over 8% After Earnings; Tencent, Alibaba, and Meituan Gain 4%
Market Performance: The Hong Kong bourse experienced a strong morning session, with the Hang Seng Index (HSI) rising 468 points (1.85%) to close at 25,789, driven by gains in technology stocks.
JD Companies Surge: JD's various subsidiaries saw significant stock price increases following their earnings release, with JD Logistics soaring 21.3% and JD Health rising 3.5%.
Tech Stocks Gains: Major tech companies like Tencent, Alibaba, and Meituan also posted notable gains, with increases ranging from 3.9% to 4.3%, contributing to the overall market upswing.
AI and Cloud Stocks: AI-related stocks and cloud service providers experienced growth, with companies like Kingsoft Cloud and various AI firms seeing increases of 3.7% to 5.7%, while Bilibili's stock fell despite reporting a significant profit increase.
HSBC Research Lowers KINGDEE INT'L (00268.HK) Price Target to $17.7, Maintains Buy Rating
Share Price Movement: KINGDEE INT'L's share price has decreased by 3.027% recently, despite a 24% year-to-date increase, amid concerns about AI's impact on software.
HSBC Global Research Insights: HSBC believes that while AI can enhance ERP systems, it will not replace them due to the complexity and high expectations of corporate clients.
Revenue Model Differences: Unlike the US software sector, KINGDEE INT'L charges based on the number of modules used rather than a seat-based model, reflecting the competitive landscape in China.
Profit Forecast Adjustments: HSBC has lowered its net profit forecasts for KINGDEE INT'L by 14-25% for 2025-2027, while maintaining a Buy rating and adjusting the target price from $18.2 to $17.7.
HSI Closes Down 491 Points; Tech, Pharma, and Chinese Insurers Decline, While STANCHART Surges Over 3% After Earnings Report
Market Performance: The HSI fell by 491 points (1.8%) to 26,590, with the HSCEI and HSTECH also experiencing declines of 2.1%, closing at 9,007 and 5,270 respectively, amid a total market turnover of HKD250.992 billion.
Tech Stock Declines: Major tech stocks like TENCENT, BABA-W, and MEITUAN-W saw significant drops, with short selling ratios indicating high market activity, reflecting a broader downturn in the tech sector.
Pharmaceutical Sector Struggles: Pharmaceutical stocks continued to decline, with CSPC PHARMA and SINO BIOPHARM among the biggest losers, as short selling activity remained high in this sector.
Financial Sector Highlights: STANCHART reported a 3.1% increase in stock price after announcing a significant rise in dividend distribution, contrasting with the overall negative trend seen in Chinese insurers, which experienced declines.
HSI Declines 523 Points at Midday; KNOWLEDGE ATLAS Gains 20%; Tech, Pharma, and Chinese Insurers Underperform
Market Performance: The HSI fell 523 points (1.9%) to 26,558, with the HSCEI down 190 points (2.1%) and the HSTECH dropping 127 points (2.4%), amid a total turnover of HKD138.679 billion.
Tech Stocks Decline: Major tech stocks like TENCENT, BABA-W, and MEITUAN-W experienced significant declines, with short selling ratios indicating increased bearish sentiment.
AI and Robotics Sector Struggles: Stocks in the AI sector, including SENSETIME-W and PHANCY, saw substantial losses, while robotics stocks like DOBOT plunged over 10%.
Pharmaceutical and Insurance Stocks Down: Pharma stocks such as CSPC PHARMA and Chinese insurers like CHINA LIFE faced declines of 4-6%, reflecting a broader downturn in these sectors.
G Sachs: KINGDEE INT'L (00268.HK) Anticipated to Report Over RMB60M Profit Last Year, Falling Short of Projections; Target Price Reduced to $18.21
Goldman Sachs Outlook: Goldman Sachs maintains a positive outlook on KINGDEE INT'L (00268.HK), leveraging AI and corporate data to enhance productivity, despite a recent stock decline of 5.645%.
Profit Forecast: KINGDEE INT'L is expected to turn a profit in 2025, projecting a net profit of RMB60-100 million, although this is lower than previous estimates of RMB178 million.
Revised Profit Estimates: Goldman Sachs has reduced its profit forecasts for KINGDEE INT'L for 2025-2027 by 47%, 8%, and 6% respectively, citing higher-than-expected operating expenses.
Target Price Adjustment: The broker has lowered its target price for KINGDEE INT'L from $18.98 to $18.21 while maintaining a "Buy" rating.
